Thank you for your submission. The information will be live within the next 24-48 hours.
AstraZeneca - ADDC Collaboration
The collaboration allows for ADDC members to have direct access to the AstraZeneca's library of compounds.
This collaboration between ADDC and AstraZeneca is aimed at at facilitating efforts by researchers from academia and institutions towards the discovery of novel compounds with potential pharmaceutical application.
Click here for more information
Highlighted Partnerships
California Institute for Quantitative Biosciences (QB3) |
|
QB3 isa tri-campus organization at UC Berkeley, UC San Francisco, and UC Santa Cruz. QB3 is the University of California’s hub for innovation and entrepreneurship in the life sciences. The... |
Royal Society of Chemistry |
|
Led by Hiroaki Suga (University of Tokyo), RSC Chemical Biology is a gold open access journal, dedicated to publishing exceptionally significant and breakthrough findings of... |
CDRD |
|
Share resources for the discovery of new drugs stemming rom CDRD and IPS. |
Creative BioMart |
|
|
CEO |
|
development of peptide therapeutics to metastatic cancer |
Therapeuitic Areas of Expertise
-
ChoicesPercentage
-
Oncology32.65%
-
Infectious Diseases16.33%
-
Neurological Disorders32.65%
-
Immunology24.49%
-
Metabolic Disorders22.45%
-
Cardiology14.29%
-
Pain8.16%
-
Other12.24%
-
Therapeutic Approaches
-
ChoicesPercentage
-
Small Molecules77.55%
-
Biologics40.82%
-
Biomarkers4.08%
-
Drug Delivery4.08%
-
Stem Cells4.08%
-
Vaccines2.04%
-
Antibodies10.2%
-
Other2.04%
-